A new HIV prevention drug will be made available at a lower cost in over 100 low-income countries within two years, including across Africa. It's a move expected to give millions access to the breakthrough treatment and potentially bring the world closer to ending the HIV/Aids epidemic. So, how affordable and effective is it?

Also, Zimbabwe continues on a quest to become Africa’s blueberry capital after recently signing a tariff free export agreement with China, one of the largest consumers of the fruit. What impact will it have on the country?

And why students in Europe are learning Hausa, a language spoken by millions of people in West Africa

Presenter: Charles Gitonga